Sunday, November 22, 2026
Freedom Online
  • Home
  • News
    • Foreign
    • Crime
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates
No Result
View All Result
Freedom Online
  • Home
  • News
    • Foreign
    • Crime
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates
No Result
View All Result
Freedom Online
No Result
View All Result

Researchers test new vaccine that may cure ‘advanced’ cancer

Freedom Reporter by Freedom Reporter
March 3, 2016
in Health, News
0
Share on FacebookShare on TwitterShare on Whatsapp

A team of researchers is testing a new vaccine in Britain, which is aimed at enabling the immune system to fight against advanced cancer.
The King’s College London announced on Thursday that the VAPER trial is taking place at universities and research institutes in London.
It said a Surrey hospital and research centre is expected to commence patient recruitment later this year.
The college said in its publication that the first two patients have already been vaccinated in a trial that is anticipated to run for 18 to 24 months.
It said the trial was aimed at establishing the benefits of the vaccination programme, any side effects and the impact of the treatment on patients’ quality of life.
Researchers expressed the hope that the results would take them one step closer to developing an effective but non-toxic cancer therapy that can be used in clinical practice.
Dr James Spicer, one of the lead researchers in the team, said the vaccine works by resembling the natural immune responses generated by the body against bacterial and viral infections.
He said all patients with any solid tumour, irrespective of their type of cancer and tumour genetic profile, are believed to have the potential to benefit from this sort of treatment.
“The unique feature of this study is the use of additional agents to boost the vaccination response.
“It is hoped this will abolish the inhibitory effect of regulatory immune cells present in the patients’ circulation, which are believed to have limited the effectiveness of previous cancer vaccine approaches,” he said.
Spicer said the design of the VAPER trial builds on results obtained from previous pilot immunotherapy studies and is supported by data from related trials carried out in the UK, U.S. and elsewhere in Europe.
He said should the trial prove successful, it would be expanded to a larger number of patients to further assess its effectiveness.

Tags: cancervaper
Share25Tweet16Send
Previous Post

Court remands motorcyclist for allegedly raping passenger

Next Post

Agatu killings: Senate wants arms retrieved from herdsmen

Next Post

Agatu killings: Senate wants arms retrieved from herdsmen

Copyright Infringement: MTN loses bid to stop trial

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

https://freedomonline.com.ng/wp-content/uploads/2026/04/VID-20260408-WA0025.mp4
https://freedomonline.com.ng/wp-content/uploads/2025/01/5aeac180-db4e-4e7c-bd37-07ddbf15b053.mp4

Popular Stories

Plugin Install : Popular Post Widget need JNews - View Counter to be installed

Latest Stories

Hajia Yemi Sowunmi-Kolapo

Ogun PDP Deputy Guber candidate, Yemi Kolapo, installed first Akinkanju of Egbaland

November 22, 2026
Motsepe and Infantino

CAF records $31.2m profit, revenue exceeds $284m; adopts Kiswahili as fifth official language, backs Infantino’s re-election

November 22, 2026

EPL: Leeds record historic huge win as Arsenal, Man City drop points

November 22, 2026

Succession crisis in Nigerian churches: Matters arising, by Bolanle Bolawole

November 22, 2026

High Volume of Election Litigations Not Translated Into Widespread Vindication–Appeal Court Justice 

November 22, 2026

Anambra CityBoy Members Threaten Mass Exit Over Leadership Crisis Ahead of 2027

November 21, 2026

2027 WASSCE: Ondo Government Cracks Down on Miracle Centres and Exam Fraud

November 21, 2026
Freedom Online

© 2026 Published by SWAAYA LIMITED, Plot 20, Block G, Scheme 1, Residential 3, OPIC Beachland Estate, Lagos/Ibadan Expressway, Lagos. Gabriel Akinadewo, MD/CEO 08023010222, 08094000056, 08052097814.

Navigate Site

  • Home
  • News
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates

Follow Us

No Result
View All Result

© 2026 Published by SWAAYA LIMITED, Plot 20, Block G, Scheme 1, Residential 3, OPIC Beachland Estate, Lagos/Ibadan Expressway, Lagos. Gabriel Akinadewo, MD/CEO 08023010222, 08094000056, 08052097814.